VI Therapeutics
VI Therapeutics is developing novel therapies for rare genetic diseases.
About
VI Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. They leverage their proprietary gene editing and delivery technologies to create transformative treatments for patients with unmet medical needs. Teams look it up for Life Sciences, Biotech, MedTech.
Frequently asked
What does VI Therapeutics do?
VI Therapeutics is a Life Sciences company that offers Services. Teams look it up for Biotech, MedTech, HealthTech. It is based in Cambridge, United States and was founded in 2017. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is VI Therapeutics headquartered?
VI Therapeutics is headquartered in Cambridge, United States.
When was VI Therapeutics founded?
VI Therapeutics was founded in 2017.
What industry does VI Therapeutics operate in?
VI Therapeutics operates in Life Sciences, Biotech, MedTech, HealthTech, Genomics.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.